Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07447076 · ClinicalTrials.gov registry record · Phase 2
Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)
A Phase 2 study, sponsored by Sabine Mueller, MD, PhD.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 29
- Enrollment target
NCT07447076 is a Phase 2 study that is actively recruiting participants, run by Sabine Mueller, MD, PhD. The registered enrollment target is 29 participants.
The verdict
NCT07447076, a Phase 2 study, is actively recruiting participants, sponsored by Sabine Mueller, MD, PhD.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 29 participants
- Enrollment target
Study Summary
This is a multi-treatment arm study that will be conducted through the Pacific Pediatric Neuro-oncology Consortium (PNOC).The study will assess the safety and efficacy of novel therapies and combinatorial strategies for participants with recurrent or progressive ATRT.
Interventions
- PROCEDURE Magnetic resonance imaging (MRI)
- DRUG Gemcitabine
- DRUG Paxalisib
- PROCEDURE Blood Specimen Collection
- PROCEDURE Lumber Puncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2026-06-17 |
| Est. Completion | 2036-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07447076
The ClinicalTrials.gov registry entry for NCT07447076 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sabine Mueller, MD, PhD, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Magnetic resonance imaging (MRI) is the first listed.
NCT07447076 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07447076 about?
NCT07447076 is a clinical study titled "Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)". This is a multi-treatment arm study that will be conducted through the Pacific Pediatric Neuro-oncology Consortium (PNOC).The study will assess the safety and efficacy of novel therapies and combinatorial strategies for participants with recurrent or progressive ATRT.
What is the current status of trial NCT07447076?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 29 participants. The study started on 2026-06-17. Estimated completion is 2036-12-31.
What interventions are being tested in trial NCT07447076?
The interventions under investigation include: Magnetic resonance imaging (MRI) (PROCEDURE), Gemcitabine (DRUG), Paxalisib (DRUG), Blood Specimen Collection (PROCEDURE), Lumber Puncture (PROCEDURE).
Who is sponsoring clinical trial NCT07447076?
This trial is sponsored by Sabine Mueller, MD, PhD, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.